RE: Peoples thoughts24 Mar 2024 17:55
If you took the MCAP @ IPO of 40M then that would create a sp of 22.60p and if it reached the 80M you suggested then sp 45.20p. I could see 25p being reached pretty quickly as it is difficult with relatively small free float shares as the price can accelerate very quickly in deed. I have been desperately trying to dig out the original broker sp rating for Geni at IPO but cannot find it for the life of me so if anybody has got that info then please let me know but from memory it was £1.79 on FDA approval but I could I be wrong as it was some time ago. Obviously there has been dilution since but lets remember that circa 50M Euro was spent on research and development before IPO, and now ROCA has NICE approval, Euroean markets are expanding including Germany and the NHS and CLIA lab certification in California with Lipidincode and CIC being processed through that facility. These are great times for Geni and it reiterates the current sp value. Lets keep the news flow going, GLA and DYOR Swissy.